| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 肌肽系列(元) | 61,006,415.46 | 33,274,057.89 | 45,452,968.58 | 26,892,475.41 |
| 磷脂酰胆碱系列(元) | 42,704,670.59 | 13,322,335.84 | 41,094,282.41 | 25,228,033.05 |
| 硫辛酸系列(元) | 270,662,636.17 | 147,826,799.85 | 276,481,081.94 | 143,395,475.85 |
| 艾瑞昔布(元) | 52,804,348.66 | 26,591,184.08 | 62,978,472.56 | - |
| 营业成本(元) | ||||
| 肌肽系列(元) | 45,475,202.80 | 24,638,800.05 | 32,997,803.10 | 18,275,877.63 |
| 磷脂酰胆碱系列(元) | 37,301,387.30 | 11,036,637.24 | 25,045,029.75 | 15,722,144.33 |
| 硫辛酸系列(元) | 230,086,228.96 | 123,324,403.53 | 226,558,999.20 | 113,272,288.76 |
| 艾瑞昔布(元) | 41,612,895.99 | 20,837,284.92 | 55,928,462.04 | - |
| 毛利(元) | ||||
| 肌肽系列(元) | 15,531,212.66 | 8,635,257.84 | 12,455,165.48 | 8,616,597.78 |
| 磷脂酰胆碱系列(元) | 5,403,283.29 | 2,285,698.60 | 16,049,252.66 | 9,505,888.72 |
| 硫辛酸系列(元) | 40,576,407.21 | 24,502,396.32 | 49,922,082.74 | 30,123,187.09 |
| 艾瑞昔布(元) | 11,191,452.67 | 5,753,899.16 | 7,050,010.52 | - |
| 毛利率(%) | ||||
| 肌肽系列(%) | 25.46 | 25.95 | 27.40 | 32.04 |
| 磷脂酰胆碱系列(%) | 12.65 | 17.16 | 39.05 | 37.68 |
| 硫辛酸系列(%) | 14.99 | 16.58 | 18.06 | 21.01 |
| 艾瑞昔布(%) | 21.19 | 21.64 | 11.19 | - |
| 收入构成(%) | ||||
| 肌肽系列(%) | 14.28 | 15.06 | 10.67 | 13.75 |
| 磷脂酰胆碱系列(%) | 10.00 | 6.03 | 9.65 | 12.90 |
| 硫辛酸系列(%) | 63.36 | 66.89 | 64.90 | 73.34 |
| 艾瑞昔布(%) | 12.36 | 12.03 | 14.78 | - |
| 毛利构成(%) | ||||
| 肌肽系列(%) | 21.36 | 20.97 | 14.57 | 17.86 |
| 磷脂酰胆碱系列(%) | 7.43 | 5.55 | 18.78 | 19.70 |
| 硫辛酸系列(%) | 55.81 | 59.50 | 58.40 | 62.44 |
| 艾瑞昔布(%) | 15.39 | 13.97 | 8.25 | - |